FDA declines to approve Intellipharma's opioid painkiller
Zawya Intellipharmaceutics International Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve its long-acting opioid painkiller in its current form, backing its independent advisory panel that had raised concerns over the drug's ... |
from Health - Google News http://ift.tt/2flu1IV
EmoticonEmoticon